Big Pharma To Invest More On NCD Partnerships Over Next Decade – IFPMA Report
This article was originally published in PharmAsia News
Executive Summary
Although Big Pharma is investing more in partnerships related to non-communicable diseases such as cancer and diabetes, gaps remain in tech transfer activities and local solutions in developing nations where NCDs are on the rise.